Title:
APTAMERS TO HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-3
Document Type and Number:
WIPO Patent Application WO2005040339
Kind Code:
A3
Abstract:
The disclosure provided herein provides compositions of nucleic acid aptamers that bind human epidermal growth factor receptor-3 and methods for their use.
More Like This:
Inventors:
CHEN CHI-HONG B (US)
LANDGRAF RALF (US)
LANDGRAF RALF (US)
Application Number:
PCT/US2004/023039
Publication Date:
December 21, 2006
Filing Date:
July 16, 2004
Export Citation:
Assignee:
UNIV CALIFORNIA (US)
CHEN CHI-HONG B (US)
LANDGRAF RALF (US)
CHEN CHI-HONG B (US)
LANDGRAF RALF (US)
International Classes:
C07H21/04; C12N15/115; C12Q1/68; C12N
Other References:
GULLICK J.W.: "The c-erbB3/HER3 receptor in human cancer", CANCER SURVEYS, vol. 27, 1996, pages 339 - 349, XP008073872
CHEN C.B. ET AL.: "Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 100, no. 16, August 2003 (2003-08-01), pages 9226 - 9231, XP002303440
CHEN C.B. ET AL.: "Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 100, no. 16, August 2003 (2003-08-01), pages 9226 - 9231, XP002303440
Download PDF:
Previous Patent: CONSTRAINED ALKALOID IMMUNOGENS AND ANTIBODIES AND USES THEREOF
Next Patent: RNAI-BASED MODIFICATION OF HETEROCHROMATIN
Next Patent: RNAI-BASED MODIFICATION OF HETEROCHROMATIN